Page 8 - Bioscience Inc News Today

Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) and TerrAscend (OTCMKTS:TSNDF – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends. Valuation and Earnings This table compares Green Thumb […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.42 and traded as low as $0.33. Daré Bioscience shares last traded at $0.34, with a volume of 233,070 shares changing hands. Analysts Set New Price […]

Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading

In this article, we will be analyzing the age structures globally while covering the 30 countries with the lowest median age in the world.

Utah Medical Products (NASDAQ:UTMD – Get Free Report) and INVO Bioscience (NASDAQ:INVO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation. Analyst Ratings This is a summary […]

In this article, we will be navigating through adolescent fertility across the world while covering the 20 countries with the highest teenage pregnancy rates.

Shares of Symbotic Inc. (NASDAQ: SYM) surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results.

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Free Report) – Equities researchers at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Yield10 Bioscience in a report issued on Thursday, November 16th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings of $0.05 per share for the year, down […]

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Free Report) – HC Wainwright lowered their FY2027 earnings estimates for Yield10 Bioscience in a note issued to investors on Thursday, November 16th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings per share of $0.05 for the year, down from their prior estimate […]

Operator: Hello and welcome to the Third Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience.